SANDANAYAKA Vincent P.,SHECHTER Sharon,SHACHAM Sharon,MCCAULEY Dilara,BALOGLU Erkan
申请号：
SI201331730
公开号：
SI3404027T1
申请日:
2013.05.09
申请国别(地区):
SI
年份:
2020
代理人:
摘要：
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
